Evidence map›Paper›PMID 28152512›Full record

ArticleOncotarget2017

Klotho suppresses the inflammatory responses and ameliorates cardiac dysfunction in aging endotoxemic mice.

Haipeng Hui, Yufeng Zhai, Lihua Ao, Joseph C Cleveland, Hongbin Liu, David A Fullerton, Xianzhong Meng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2024
    Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Haipeng HuiDepartment of Surgery, University of Colorado Denver, Aurora, USA.
Yufeng ZhaiDepartment of Surgery, University of Colorado Denver, Aurora, USA.
Lihua AoDepartment of Surgery, University of Colorado Denver, Aurora, USA.
Joseph C ClevelandDepartment of Surgery, University of Colorado Denver, Aurora, USA.
Hongbin LiuDepartment of Geriatric Cardiology, PLA General Hospital, Beijing, China.
David A FullertonDepartment of Surgery, University of Colorado Denver, Aurora, USA.
Xianzhong MengDepartment of Surgery, University of Colorado Denver, Aurora, USA.
University of Colorado Denver · USChinese PLA General Hospital · CN

Funding

Inflammatory response of aging heart to surgical myocardial ischemiaR01AG039545 · NIA · UNIVERSITY OF COLORADO DENVER · PI MENG, XIANZHONG · 2011 to 2015
$1.5M
NIA NIH HHS R01 AG039545
6 · The paper itself

Abstract

backgroundAging augments endotoxemic cardiac dysfunction, but the mechanism remains unclear. Anti-aging protein Klotho has been found to modulate tissue inflammatory responses. We tested the hypothesis that a reduced Klotho level in aging heart plays a role in the augmented endotoxemic cardiac dysfunction. MATERIALS AND

methodsEndotoxin (0.5 mg/kg, iv) was injected to adults (4-6 months) and aging (18-20 months) C57BL/6 mice. Recombinant Klotho (10 μg/kg, iv) was administered to a group of aging mice after endotoxin injection. Cardiac function was analyzed using a microcatheter at 24 and 48 h after endotoxin administration. Myocardial levels of Klotho and heat shock protein 70 (HSP70) were determined by immunoblotting, and plasma and myocardial cytokines were analyzed using ELISA.

resultsMore severe cardiac dysfunction in aging mice were accompanied by greater cytokine levels in the plasma and myocardium. Klotho was detected in the myocardial tissue. Klotho levels were lower in aging hearts and were further reduced during endotoxemia. Myocardial HSP70 levels were correlated with Klotho levels. Recombinant Klotho increased myocardial HSP70, inhibited NF-κB activation, reduced cytokine levels, and improved cardiac function in aging endotoxemic mice. Delivery of HSP70 into cultured macrophages suppressed endotoxin-induced NF-κB activation.

conclusionsAging-related augmentation of inflammatory responses and cardiac dysfunction is associated with relative Klotho deficiency. Post-treatment with recombinant Klotho suppresses the inflammatory responses and improves cardiac function in aging endotoxemic mice. Klotho modulates HSP70 levels and HSP70 appears to be involved in the anti-inflammatory mechanism of Klotho. Klotho may have therapeutic potential in amelioration of aging-related endotoxemic cardiac dysfunction.

Indexed as

AgingAnimalsCytokinesEndotoxemiaEnzyme-Linked Immunosorbent AssayGlucuronidaseHeartHSP70 Heat-Shock ProteinsImmunoblottingInflammationKlotho ProteinsLipopolysaccharidesMaleMice, Inbred C57BLMyocardiumRecombinant ProteinsCytokinesGlucuronidaseHSP70 Heat-Shock ProteinsKlotho ProteinsLipopolysaccharidesRecombinant Proteinsagingendotoxemic cardiac dysfunctionheat shock proteininflammationKlotho

Identifiers

PMID28152512
PMCPMC5362514
OpenAlexW2583369330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.